In the Fight Against Long COVID, Paxlovid Offers Limited Protection
The antiviral combination nirmatrelvir-ritonavir (Paxlovid) used for early symptoms of COVID-19 offers limited protection against the development of Long COVID.
Combining Fluvoxamine and Inhaled Budesonide for COVID-19 Treatment
Combining the two drugs appears more likely to reduce risk of early COVID-19 symptoms worsening than taking either one on its own.
2 Commerce Drive Cranbury, NJ 08512